Close

Quotient (QTNT) Provides Update on MosaiQ Expanded Immunohematology Microarray CE Marking Progress

December 15, 2021 8:31 AM EST

Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced the company received feedback from the European notified body on the Expanded Immunohematology (IH) submission. The Company is pleased with the feedback and expects to submit a response to the questions in the next couple of weeks.

“I’m very pleased with the recent news and thankful for progress the team has made with this submission. I’m looking forward to executing on our commercialization in the first quarter of next year,” said Manuel O. Méndez, Chief Executive Officer of Quotient.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, FDA